Kosuke Hamai

6PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 22, 2026
Pulmonary carcinoid harboring a KRAS G12C mutation identified through comprehensive genomic profiling and responding to sotorasib: A case report.

|Aug 09, 2024
A Retrospective Analysis of the Efficacy of Oral Dexamethasone in Combination With Docetaxel Plus Ramucirumab Therapy for Previously Treated Lung Cancer.

Kosuke Hamai, Ryo Katsura, Shinya Miyake

|Feb 02, 2023
Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer.

Kosuke Hamai, Shinya Miyaka, Shinpei Tada

|Apr 30, 2022
Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1.

Takeshi Masuda, Kazunori Fujitaka, Tomoko Suzuki

|Apr 16, 2020
First-line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD-L1: A case report.

Kosuke Hamai, Hiroki Tanahashi, Sayaka Ueno

|May 23, 2018
Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding.

Kosuke Hamai, Hiroshi Iwamoto, Shinichiro Ohshimo

Pageof 1

Frequent Collaborators

2 joint publications

Nobuhisa Ishikawa

1 joint publications

Takeshi Masuda

1 joint publications

Kakuhiro Yamaguchi